vs

Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Smart Sand, Inc. (SND). Click either name above to swap in a different company.

Smart Sand, Inc. is the larger business by last-quarter revenue ($86.0M vs $62.1M, roughly 1.4× Cytek Biosciences, Inc.). Smart Sand, Inc. runs the higher net margin — 1.4% vs -70.9%, a 72.3% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs -5.8%). Smart Sand, Inc. produced more free cash flow last quarter ($20.4M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 1.8%).

Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.

Sand 9 is a fabless Micro-electromechanical system (MEMS) company based in Cambridge, Massachusetts. Sand 9 developed a piezoelectric MEMS resonator to serve as an alternative for quartz timing devices in applications such as smart phones, low-power wireless devices, and communications infrastructure equipment.

CTKB vs SND — Head-to-Head

Bigger by revenue
SND
SND
1.4× larger
SND
$86.0M
$62.1M
CTKB
Growing faster (revenue YoY)
CTKB
CTKB
+13.9% gap
CTKB
8.1%
-5.8%
SND
Higher net margin
SND
SND
72.3% more per $
SND
1.4%
-70.9%
CTKB
More free cash flow
SND
SND
$22.1M more FCF
SND
$20.4M
$-1.8M
CTKB
Faster 2-yr revenue CAGR
CTKB
CTKB
Annualised
CTKB
17.7%
1.8%
SND

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTKB
CTKB
SND
SND
Revenue
$62.1M
$86.0M
Net Profit
$-44.1M
$1.2M
Gross Margin
52.9%
13.0%
Operating Margin
-9.0%
-3.1%
Net Margin
-70.9%
1.4%
Revenue YoY
8.1%
-5.8%
Net Profit YoY
-557.1%
-68.5%
EPS (diluted)
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTKB
CTKB
SND
SND
Q4 25
$62.1M
$86.0M
Q3 25
$52.3M
$92.8M
Q2 25
$45.6M
$85.8M
Q1 25
$41.5M
$65.6M
Q4 24
$57.5M
$91.4M
Q3 24
$51.5M
$63.2M
Q2 24
$46.6M
$73.8M
Q1 24
$44.9M
$83.1M
Net Profit
CTKB
CTKB
SND
SND
Q4 25
$-44.1M
$1.2M
Q3 25
$-5.5M
$3.0M
Q2 25
$-5.6M
$21.4M
Q1 25
$-11.4M
$-24.2M
Q4 24
$9.6M
$3.7M
Q3 24
$941.0K
$-98.0K
Q2 24
$-10.4M
$-430.0K
Q1 24
$-6.2M
$-216.0K
Gross Margin
CTKB
CTKB
SND
SND
Q4 25
52.9%
13.0%
Q3 25
52.7%
16.1%
Q2 25
52.3%
10.4%
Q1 25
48.6%
4.2%
Q4 24
58.5%
14.7%
Q3 24
56.3%
10.3%
Q2 24
54.6%
17.7%
Q1 24
51.3%
14.2%
Operating Margin
CTKB
CTKB
SND
SND
Q4 25
-9.0%
-3.1%
Q3 25
-17.6%
5.8%
Q2 25
-23.3%
-0.1%
Q1 25
-36.1%
-10.8%
Q4 24
5.2%
3.9%
Q3 24
-8.2%
-7.8%
Q2 24
-18.3%
4.8%
Q1 24
-23.9%
0.9%
Net Margin
CTKB
CTKB
SND
SND
Q4 25
-70.9%
1.4%
Q3 25
-10.5%
3.2%
Q2 25
-12.2%
24.9%
Q1 25
-27.5%
-37.0%
Q4 24
16.8%
4.1%
Q3 24
1.8%
-0.2%
Q2 24
-22.4%
-0.6%
Q1 24
-13.8%
-0.3%
EPS (diluted)
CTKB
CTKB
SND
SND
Q4 25
$0.03
Q3 25
$0.08
Q2 25
$0.54
Q1 25
$-0.62
Q4 24
$0.10
Q3 24
$0.00
Q2 24
$-0.01
Q1 24
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTKB
CTKB
SND
SND
Cash + ST InvestmentsLiquidity on hand
$90.9M
$22.6M
Total DebtLower is stronger
$15.0M
Stockholders' EquityBook value
$341.7M
$239.7M
Total Assets
$461.5M
$340.0M
Debt / EquityLower = less leverage
0.06×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTKB
CTKB
SND
SND
Q4 25
$90.9M
$22.6M
Q3 25
$93.3M
$5.1M
Q2 25
$75.5M
$4.3M
Q1 25
$95.3M
$5.1M
Q4 24
$98.7M
$1.6M
Q3 24
$162.3M
$7.2M
Q2 24
$177.9M
$6.3M
Q1 24
$168.8M
$4.6M
Total Debt
CTKB
CTKB
SND
SND
Q4 25
$15.0M
Q3 25
$14.3M
Q2 25
$23.5M
Q1 25
$13.7M
Q4 24
$14.7M
Q3 24
$15.7M
Q2 24
$17.1M
Q1 24
$25.5M
Stockholders' Equity
CTKB
CTKB
SND
SND
Q4 25
$341.7M
$239.7M
Q3 25
$378.6M
$239.9M
Q2 25
$377.6M
$240.5M
Q1 25
$379.6M
$219.9M
Q4 24
$395.7M
$243.8M
Q3 24
$385.5M
$243.6M
Q2 24
$389.1M
$242.9M
Q1 24
$392.6M
$242.5M
Total Assets
CTKB
CTKB
SND
SND
Q4 25
$461.5M
$340.0M
Q3 25
$494.9M
$343.1M
Q2 25
$493.3M
$345.8M
Q1 25
$482.6M
$326.9M
Q4 24
$499.5M
$341.5M
Q3 24
$491.2M
$335.8M
Q2 24
$483.7M
$341.8M
Q1 24
$492.1M
$349.3M
Debt / Equity
CTKB
CTKB
SND
SND
Q4 25
0.06×
Q3 25
0.06×
Q2 25
0.10×
Q1 25
0.06×
Q4 24
0.06×
Q3 24
0.06×
Q2 24
0.07×
Q1 24
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTKB
CTKB
SND
SND
Operating Cash FlowLast quarter
$-771.0K
$22.4M
Free Cash FlowOCF − Capex
$-1.8M
$20.4M
FCF MarginFCF / Revenue
-2.9%
23.7%
Capex IntensityCapex / Revenue
1.6%
2.3%
Cash ConversionOCF / Net Profit
18.99×
TTM Free Cash FlowTrailing 4 quarters
$-8.8M
$32.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTKB
CTKB
SND
SND
Q4 25
$-771.0K
$22.4M
Q3 25
$-3.9M
$18.2M
Q2 25
$108.0K
$-5.1M
Q1 25
$-125.0K
$8.7M
Q4 24
$2.0M
$1.0M
Q3 24
$13.2M
$5.8M
Q2 24
$6.2M
$14.9M
Q1 24
$4.0M
$-3.9M
Free Cash Flow
CTKB
CTKB
SND
SND
Q4 25
$-1.8M
$20.4M
Q3 25
$-4.6M
$14.8M
Q2 25
$-1.5M
$-7.8M
Q1 25
$-974.0K
$5.2M
Q4 24
$1.1M
$-840.0K
Q3 24
$12.2M
$3.7M
Q2 24
$5.2M
$13.5M
Q1 24
$3.4M
$-5.5M
FCF Margin
CTKB
CTKB
SND
SND
Q4 25
-2.9%
23.7%
Q3 25
-8.7%
15.9%
Q2 25
-3.2%
-9.1%
Q1 25
-2.3%
7.9%
Q4 24
1.9%
-0.9%
Q3 24
23.7%
5.8%
Q2 24
11.0%
18.3%
Q1 24
7.6%
-6.6%
Capex Intensity
CTKB
CTKB
SND
SND
Q4 25
1.6%
2.3%
Q3 25
1.3%
3.6%
Q2 25
3.5%
3.1%
Q1 25
2.0%
5.4%
Q4 24
1.6%
2.1%
Q3 24
2.0%
3.4%
Q2 24
2.3%
1.8%
Q1 24
1.3%
2.0%
Cash Conversion
CTKB
CTKB
SND
SND
Q4 25
18.99×
Q3 25
6.05×
Q2 25
-0.24×
Q1 25
Q4 24
0.21×
0.28×
Q3 24
14.05×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTKB
CTKB

Products$46.6M75%
Services$15.5M25%

SND
SND

Sand$85.1M99%
Smart Systems Segment$980.0K1%

Related Comparisons